| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.28 | 1e-09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |